Neutrogena and Aveeno Sunscreens
Allegations: Failing to disclose products contain the carcinogen benzene
June 2020: A federal court judge granted final approval of the settlement agreement.
December 2019: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for June 22, 2020. For more information, go to http://www.infantstylenolsettlement.com/.
September 2019: Plaintiffs moved for preliminary approval of a proposed settlement agreement. According to its terms, class members with proof of purchase may receive $2.15 for every bottle of Infants’ Tylenol purchased while class members without proof of purchase may receive $2.15 for up to seven bottles purchased (or a maximum award of $15.05). In addition, the company agreed to make changes to marketing materials for a period of two years, including modifying the image on the packaging for Infants’ Tylenol so that the child shown is at least two years old and disclosing on its websites and dosage charts for healthcare providers, as well as to consumers who complain or inquire, that the Infants’ and Children’s medicines contain the same concentration of acetaminophen.
November 2017: Plaintiffs filed an amended complaint similarly alleging that Infants’ Tylenol is marketed as “specially formulated for babies” when, according to the complaint, it is the same as the Children’s Tylenol.
October 2017: A class-action lawsuit was filed against Johnson & Johnson Consumer Inc. for allegedly deceptively representing that Children’s Tylenol and Infants’ Tylenol are different products in order to get consumers to pay more for Infants’ Tylenol when, according to plaintiffs, the medicines contain the same ingredients and the same dosages. (Elkies et al v. Johnson & Johnson Services, Inc. and Johnson & Johnson Consumer Inc., Case No. 17-cv-7320, C. D. Cal.)
For more of TINA.org’s coverage of the marketing of Tylenol products, click here.
Allegations: Failing to disclose products contain the carcinogen benzene
Allegations: Falsely marketing products as plant based
Allegations: Falsely marketing products as 100% plant-based when they contain synthetic, non-plant ingredients
Allegations: Failing to warn consumers that regularly using the product causes the proliferation of certain cancer-causing bacteria
Allegations: Misleadingly marketing that products are made with safe and high-quality ingredients, and the company is committed to the health of consumers, communities, and the planet
Allegations: Misleadingly marketing products as safe and healthy when they contain harmful per- and polyfluoroalkyl substances (PFAS)
Allegations: Misleadingly marketing products as safe, healthy, made with the “best ingredients,” environmentally friendly, and committed to the health of consumers, communities and the planet
Allegations: Misleadingly representing that products were safe when they contained, or were at risk of containing, the carcinogen benzene
Allegations: Failing to disclose that products contain high levels of the carcinogen benzene
Allegations: Falsely marketing products as “Preservative-Free”
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat congestion and other sinus issues
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely advertising sunscreens as waterproof
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that products treat nasal congestion
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing products as decongestants
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that medicines relieve nasal congestion and sinus pressure
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines relieve nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing products as decongestants
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal decongestion
Allegations: Falsely marketing that medicines treat sinus pressure and nasal congestion
Allegations: Falsely marketing that medicines treat congestion and other sinus issues
Allegations: Falsely marketing that medicines treat nasal decongestion
Allegations: Misleadingly marketing products as specially made for babies when they contain the same formulation as the adult versions
Allegations: Falsely advertising that products provide faster relief than other acetaminophen products
Allegations: Misleadingly labeling products as containing no trans fats and being safe for human consumption when the spreads contain partially hydrogenated oils, which are trans fats that increase the risk…
Allegations: Failing to disclose products contain the carcinogen benzene
Allegations: Products contain more melatonin than advertised
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Allegations: Marketing products as safe without disclosing that they contain a harmful heavy metal
Allegations: Failing to disclose products contain the carcinogen benzophenone
Allegations: Misleadingly marketing that products “help[] ease occasional gas & stomach discomfort” associated with colic and hiccups in newborns when none of the ingredients have been shown to provide the…
Allegations: Misleadingly marketing that Tylenol rapid release products work faster than other products when they don’t
Allegations: Failing to disclose products contain the carcinogen benzophenone
Allegations: Falsely representing that products smooth, nourish, soften, repair and revive hair without disclosing that ingredients in the products cause significant hair loss and irritate the scalp
Allegations: Misleadingly marketing products will smooth, nourish, soften, repair and revive hair without disclosing that they contain an ingredient – DMDM hydantoin – that causes hair loss and scalp irritation
Allegations: Misleadingly advertising that supplements prevent, treat, cure and mitigate lactose intolerance without FDA approval to make such claims
Allegations: Failing to disclose sunscreens contain the carcinogen benzene
Allegations: Failing to adequately disclose that powders contain a dangerous ingredient
Allegations: Failing to disclose sunscreens contain the carcinogen benzene
Allegations: False natural claims
Allegations: Failing to disclose sunscreens contain the carcinogen benzene
Allegations: Falsely marketing the products are safe and “free of asbestos”
Allegations: False natural and chemical-free claims
In December 2020, a class-action lawsuit was filed against Johnson & Johnson Consumer Inc. for allegedly falsely advertising Neutrogena skincare products – including Hydro Boost Cleansing Gel and Oil Free…
In 2020, a class-action lawsuit was filed against Johnson & Johnson Consumer Inc. for allegedly falsely advertising Neutrogena Oil-Free Face Moisturizer for Sensitive Skin as being “Oil-Free” when, according to…
August 2020: This case was transferred from a court in California to one in New Jersey. (Case No. 20-cv-10406, D.N.J.) July 2020: The case was transferred from state court to…
December 2017: The remaining claims in this case were voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which were not disclosed. October…
November 2017: This consolidated action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. October 2017: This…
January 2018: Both appeals were voluntarily dismissed, the reasons for which were not disclosed. November 2017: A federal judge granted final approval of the settlement. Later in November, two objectors…
June 2018: The case was voluntarily dismissed because the parties reached a settlement agreement, the terms of which were not disclosed. June 2017: Plaintiffs filed an amended complaint bringing similar…
July 2019: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled. because the parties reached a settlement agreement, the terms of which have…
July 2019: A federal judge granted final approval of the settlement agreement. May 2019: Plaintiffs moved for final approval of a proposed settlement agreement that would provide class members with…
In November 2018, a class-action lawsuit was filed against Johnson & Johnson for allegedly falsely advertising the Neutrogena® Light Therapy Acne Mask and Mask Activator (an acne treatment where a…
June 2017: This case was administratively closed because the parties reached a settlement agreement and asked for 30 days to memorialize the agreement in writing. The terms of the agreement…
July 2015: The Smith action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. December 2014: This…
In May 2017, a class-action lawsuit was filed against Johnson & Johnson and McNeil Nutritionals for allegedly falsely labeling Benecol Regular and Light Spreads as containing “No Trans Fats” and…
June 2015: The parties withdrew the appeal, the reasons for which have not been disclosed. December 2014: The named plaintiff filed a Notice of Appeal regarding the November 2014 order.…
December 2016: This action was voluntarily dismissed, the reasons for which have not been disclosed. The named plaintiff’s claims were dismissed When a complaint is dismissed with prejudice, it cannot…
October 2013: This action was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled., the reasons for which have not been disclosed.…
January 2017: A federal judge granted final approval of the settlement. (Leiner et al v. Johnson & Johnson Consumer Companies, Inc., Case No. 15-cv-5876, N. D. IL.) August 2016: After…
September 2014: Plaintiffs withdrew their motion to transfer and consolidate related lawsuits. June 2014: Plaintiffs moved to transfer (i. e. move a case to another court) and consolidate (i. e.…
June 2014: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. January 2013: A class-action lawsuit…
April 2013: The case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons for the dismissal have not been disclosed. August 2012: A…
August 2013: A federal judge granted final approval of a settlement of this action. According to the settlement terms, each class member may receive up to $10 ($1 for each…
August 2015: A federal judge granted Johnson & Johnson’s and Neutrogena’s motion for summary judgment finding that there are no issues of material fact because the companies provided evidence that:…
September 2013: The named plaintiffs voluntarily dismissed this action When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons have not been…
March 2016: The parties agreed to dismiss this action and it was dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons for the dismissal have…
April 2015: This action was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons for the dismissal have not been…
October 2015: This action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons have not been disclosed. March 2015: A class-action lawsuit was…
In July 2015, a false advertising class-action lawsuit against Johnson & Johnson was dismissed When a complaint is dismissed with prejudice, it cannot be refiled. after the parties reached a…
Lawsuits allege labeling fails to disclose sunscreen products contain carcinogen.
Lawsuits claim infant-specific products aren’t any different than acetaminophen medications for older children.
NAD inquiry finds supporting evidence lacking.
The dirt on beauty and personal care products marketed as “clean.”
These claims are tough to swallow.